Sangamo BioSciences’ (SGMO) CEO Edward Lanphier on Deutsche Bank 39th Annual Health Care Conference (Transcript)

[at Seeking Alpha] – What we propose to do is human genetic engineering physically change and permanently change DNA sequences in a way that we can control the biology of that cell that will be modified that gene. So that’s … more

View todays social media effects on SGMO

View the latest stocks trending across Twitter. Click to view dashboard

See who Sangamo is hiring next, click here to view